Details for New Drug Application (NDA): 075206
✉ Email this page to a colleague
NDA 075206 describes CYTOSAR-U, which is a drug marketed by Teva Pharms Usa and is included in one NDA. Additional details are available on the CYTOSAR-U profile page.
The generic ingredient in CYTOSAR-U is cytarabine. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cytarabine profile page.
The generic ingredient in CYTOSAR-U is cytarabine. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cytarabine profile page.
Summary for 075206
| Tradename: | CYTOSAR-U |
| Applicant: | Teva Pharms Usa |
| Ingredient: | cytarabine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 075206
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/VIAL | ||||
| Approval Date: | Dec 30, 1998 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 500MG/VIAL | ||||
| Approval Date: | Dec 30, 1998 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2GM/VIAL | ||||
| Approval Date: | Dec 30, 1998 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
